| Literature DB >> 27358204 |
Li Tao1, Sheng Wang1, Yang Zhao1, Ai-Yun Wang1,2, Lei Zhang3, Jun-Shan Ruan4, Fang-Tian Fan5, Yu-Ping Liu1, Yao Li1, Zhi-Qiang Yue1, Wen-Hui Qian6, Wen-Xing Chen1,2, Yin Lu7,8.
Abstract
Accumulative evidences have underpinned the nature candidates from Chinese medicine (CM), particularly CM served as blood activating and stasis resolving (BASR, Huoxue Huayu in Chinese) by targeting tumor-associated angiogenesis. However, recent experiment research on the therapeutic angiogenesis by BASR-CM attracts wide attention and discussion. This opinion review focused on the underlying link between two indications and anticipated that (1) BASR-CM might emphasize on a balanced multi-cytokines network interaction; (2) BASR-CM might address on the nature of diseases prior to differently affecting physiological and pathological angiogenesis; (3) BASR-CM might mainly act on perivascular cells, either promotes arteriogenesis by increasing arteriogenic factors in ischemic diseases, or simultaneously keep a quiescent vasculature to impede angiogenesis in tumor context.Entities:
Keywords: Chinese medicine; anti-angiogenesis; arteriogenesis; blood activating and stasis resolving; pathological angiogenesis; physiological angiogenesis; pro-angiogenesis
Mesh:
Substances:
Year: 2016 PMID: 27358204 DOI: 10.1007/s11655-015-2405-x
Source DB: PubMed Journal: Chin J Integr Med ISSN: 1672-0415 Impact factor: 1.978